BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38243254)

  • 21. Establishment and verification of a nomogram for predicting the risk of lymph node metastasis in early gastric cancer.
    Wang Z; Liu J; Luo Y; Xu Y; Liu X; Wei L; Zhu Q
    Rev Esp Enferm Dig; 2021 Jun; 113(6):411-417. PubMed ID: 33222482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nomogram for predicting overall survival after curative gastrectomy using inflammatory, nutritional and pathological factors.
    Wang Q; Zhang Q; Zhu J; Li L; Zeng R; Ding H; Li Z; Feng T; Hao R; Zhang G
    Clin Transl Oncol; 2024 Apr; 26(4):1001-1011. PubMed ID: 37996667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nomogram to predict prolonged postoperative ileus after gastrectomy in gastric cancer.
    Liang WQ; Zhang KC; Cui JX; Xi HQ; Cai AZ; Li JY; Liu YH; Liu J; Zhang W; Wang PP; Wei B; Chen L
    World J Gastroenterol; 2019 Oct; 25(38):5838-5849. PubMed ID: 31636476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Establishment of artificial neural network model for predicting lymph node metastasis in patients with stage Ⅱ-Ⅲ gastric cancer].
    Xue Z; Lu J; Lin J; Huang CM; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Zheng CH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Apr; 25(4):327-335. PubMed ID: 35461201
    [No Abstract]   [Full Text] [Related]  

  • 25. The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.
    Xie J; Pang Y; Li X; Wu X
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2259-2269. PubMed ID: 34003367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
    Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
    J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Establishment of a nomogram model for predicting lymph node metastasis in patients with cN0 gastric cancer based on combination of preoperative C-reactive protein/albumin ratio].
    Liu Q; Peng J; Jiang HG; Wang WB; Dai J; Zhou FX
    Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):599-603. PubMed ID: 31434451
    [No Abstract]   [Full Text] [Related]  

  • 28. Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer.
    Han DS; Suh YS; Kong SH; Lee HJ; Choi Y; Aikou S; Sano T; Park BJ; Kim WH; Yang HK
    J Clin Oncol; 2012 Nov; 30(31):3834-40. PubMed ID: 23008291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual-energy CT-based deep learning radiomics can improve lymph node metastasis risk prediction for gastric cancer.
    Li J; Dong D; Fang M; Wang R; Tian J; Li H; Gao J
    Eur Radiol; 2020 Apr; 30(4):2324-2333. PubMed ID: 31953668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of nomograms for predicting overall survival and cancer-specific survival in elderly patients with locally advanced gastric cancer: a population-based study.
    Sun Y; Li Z; Tian Y; Gao C; Liang B; Cao S; Liu X; Liu X; Meng C; Xu J; Yang H; Zhou Y
    BMC Gastroenterol; 2023 Apr; 23(1):117. PubMed ID: 37041468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and verification of a nomogram for predicting the prognosis of resectable gastric cancer with outlet obstruction.
    Wei C; Li C; Chen X; Chen G; Nie R; Zhao C; Zhou Z; Chen Y
    BMC Cancer; 2022 Nov; 22(1):1154. PubMed ID: 36348289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indications for Adjuvant Chemotherapy in Stage II Gastric Cancer After D2 Gastrectomy-A Chinese Multicenter Study.
    Deng ZJ; Lu J; Nie RC; Fang JM; Chen XJ; Liu JJ; Li XZ; Chen YB; Huang CM; Lian L; Peng JS; Chen S
    Ann Surg Oncol; 2022 Dec; 29(13):8214-8224. PubMed ID: 35798893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-institutional development and validation of a nomogram to predict recurrence after curative resection of gastric neuroendocrine/mixed adenoneuroendocrine carcinoma.
    Zheng H; Zhao Y; He Q; Hao H; Tian Y; Zou B; Jiang L; Qiu X; Zhou Y; Li Z; Xu Y; Zhao G; Xue F; Li S; Fu W; Li Y; Zhou X; Li Y; Zhu Z; Chen J; Xu Z; Cai L; Li E; Li H; Xie J; Zheng C; Lu J; Li P; Huang C
    Gastric Cancer; 2021 Mar; 24(2):503-514. PubMed ID: 32915373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic accuracy of dual-energy CT-based nomograms to predict lymph node metastasis in gastric cancer.
    Li J; Fang M; Wang R; Dong D; Tian J; Liang P; Liu J; Gao J
    Eur Radiol; 2018 Dec; 28(12):5241-5249. PubMed ID: 29869176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Nomogram Based on Aspartate Aminotransferase/Alanine Aminotransferase (AST/ALT) Ratio to Predict Prognosis After Surgery in Gastric Cancer Patients.
    Li L; Zeng Q; Xue N; Wu M; Liang Y; Xu Q; Feng L; Xing S; Chen S
    Cancer Control; 2020; 27(1):1073274820954458. PubMed ID: 32959672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application value of nomogram and prognostic factors of gastric cancer patients who underwent D2 radical lymphadenectomy.
    Mu GC; Huang Y; Liu ZM; Wu XH; Qin XG; Chen ZB
    BMC Gastroenterol; 2019 Nov; 19(1):188. PubMed ID: 31729975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nomogram based on tumor-associated neutrophil-to-lymphocyte ratio to predict survival of patients with gastric neuroendocrine neoplasms.
    Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
    World J Gastroenterol; 2017 Dec; 23(47):8376-8386. PubMed ID: 29307997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nomogram analysis and external validation to predict the risk of lymph node metastasis in gastric cancer.
    Chen S; Nie RC; OuYang LY; Li YF; Xiang J; Zhou ZW; Chen Y; Peng JS
    Oncotarget; 2017 Feb; 8(7):11380-11388. PubMed ID: 28077786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Model of D2 Radical Gastrectomy Combined with Neoadjuvant Chemotherapy for Gastric Cancer.
    Wang G; Tan Y; Jiang Y; Liu J; Su Y; Sun Z; Liu B
    Risk Manag Healthc Policy; 2023; 16():1259-1271. PubMed ID: 37456825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.